ACS added to limited distribution network for Celgene's Otezla

ORLANDO, Fla. — Advanced Care Scripts, a division of Omnicare Specialty Care Group, on Wednesday announced that it has been added to the limited-distribution network for Celgene's Otezla (apremilast).

Otezlais indicated for the treatment of adult patients with active psoriatic arthritis. Otezla can help reduce symptoms of psoriatic arthritis such as joint swelling and tenderness, and joint pain. 

Otezla is the first FDA approved oral therapy for this condition, ACS noted. 



Login or Register to post a comment.